Saturday 17 October 2026
Export PBM’s income statement to Excel — free account
Psyence Biomedical Ltd.
In the quarter to September 2025, EPS was flat and free cash flow fell 707.2%, each against the same quarter a year earlier.
4.22
0.10
−2.31%
Follow PBM
| Older periods | Mar '24 | Sep '24 | Mar '25 | Sep '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
0.00% | (189.96%) | 0.00% | (23.52%) | |
| 0.00% | (0.20%) | 0.00% | (6.74%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 20.36% | 0.00% | (14.70%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | (1,125.07) | — | (34.08) | |
Free Cash Flow |
(5.33) | (6.30) | — | (8.08) | |
| Other line items | |||||
Cash ROIC |
52.25% | (891.15%) | 0.00% | (42.37%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
— | 0.00 | — | 0.00 | |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | — | 0.00% | |
Interest Coverage |
— | 0.00 | — | 0.00 | |
Operating CF/Net income |
0.00 | 24.66 | — | 8.21 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
— | 0.00 | — | 0.00 | |
Operating CF per Share |
0.00 | (1,125.07) | — | (34.08) | |
Capex per Share |
— | 0.00 | — | 0.00 |
Columns are period end dates